AGA
FLGT icon

Accuvest Global Advisors’s Fulgent Genetics FLGT Stock Holding History

Accuvest Global Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,500
Closed -$281K – 107
2022
Q1 		$281K Hold
4,500
– – 0.14% 85
2021
Q4 		$453K Hold
4,500
– – 0.2% 74
2021
Q3 		$405K Hold
4,500
– – 0.19% 78
2021
Q2 		$415K Hold
4,500
– – 0.21% 59
2021
Q1 		$435K Buy
+4,500
New +$465K 0.23% 60

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Accuvest Global Advisors's FLGT Position: Q2 2022 in Review

Accuvest Global Advisors sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 4,500 shares — an estimated $281K sold.

Accuvest Global Advisors first reported a position in FLGT in Q1 2021 and held it in 5 quarters. The position peaked at $453K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Accuvest Global Advisors reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Accuvest Global Advisors sold 4,500 Fulgent Genetics shares in Q2 2022, an estimated $281K.
  • Accuvest Global Advisors first reported a position in Fulgent Genetics in Q1 2021 and held it in 5 quarters.
  • Accuvest Global Advisors's Fulgent Genetics position peaked at $453K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Accuvest Global Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.